Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
about
Comparison of performance of the Assessment of SpondyloArthritis International Society, the European Spondyloarthropathy Study Group and the modified New York criteria in a cohort of Chinese patients with spondyloarthritisAnkylosing spondylitis: an overviewAnkylosing spondylitis: A state of the art factual backboneClinical Tools to Assess and Monitor SpondyloarthritisA registry of ankylosing spondylitis registries and prospects for global interfacingBiochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Psychological correlates of self-reported disease activity in ankylosing spondylitisCirculating protein fragments of cartilage and connective tissue degradation are diagnostic and prognostic markers of rheumatoid arthritis and ankylosing spondylitis.Treatment trials in ankylosing spondylitis: current and future considerations.Assessment of enthesitis in ankylosing spondylitis.Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis.Scoring of radiographic progression in randomised clinical trials in ankylosing spondylitis: a preference for paired reading order.Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologists.Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis.Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitisAssociation between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?Predictive factors of radiographic progression in ankylosing spondylitis.Outcomes in ankylosing spondylitis: what makes the assessment of treatment effects in ankylosing spondylitis different?Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis.Elevated Serum Levels of Soluble CD30 in Ankylosing Spondylitis Patients and Its Association with Disease Severity-Related ParametersA sonographic enthesitic index of lower limbs is a valuable tool in the assessment of ankylosing spondylitisLifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysisScoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?The clinical usefulness of multidetector computed tomography of the sacroiliac joint for evaluating spondyloarthropathiesNeutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis.Serum HMGB1 Serves as a Novel Laboratory Indicator Reflecting Disease Activity and Treatment Response in Ankylosing Spondylitis Patients.Sliding-strip microfluidic device enables ELISA on paper.Building consensus on nomenclature and disease classification for ankylosing spondylitis: results and discussion of a questionnaire prepared for the International Workshop on New Treatment Strategies in Ankylosing Spondylitis, Berlin, Germany, 18-19Spinal mobility, vertebral squaring, pulmonary function, pain, fatigue, and quality of life in patients with ankylosing spondylitis.How to diagnose axial spondyloarthritis early.Disseminated tuberculosis mimicking ankylosing spondylitis.How to diagnose axial spondyloarthropathy early.Recent advances in ankylosing spondylitis: understanding the disease and management
P2860
Q24604766-C5D4ABE3-A1C0-4CCE-95EF-8ACF9A5A4CC9Q24675044-EF69D857-331F-4921-B610-59E5E537C31EQ26782184-844AD7D6-1B79-4549-8228-C5EF5085880DQ26866120-940C549E-1BC9-4D8F-93D7-D2BD98B3F170Q27026669-35B4B5FF-8F27-4D15-B617-A794B636E789Q27687777-9C5591CD-19CF-4541-A2F5-8A6B6A6F4B53Q33874291-D27BE7F4-EDB6-41F5-9D55-92315223E3DFQ34568353-2620FC5F-0093-43FC-B946-C744F259E598Q34967507-EB9E9EFB-C3FD-482A-9EF0-B39FE644A0C2Q35552370-7DCC5887-102B-487E-9B4A-DDC8530274F7Q35553458-1F2C6C81-2297-4C75-99FE-90E123A036D5Q35553618-59D6FB74-7575-42D6-88B7-C736AB992196Q35554034-A9CF5D47-FE88-45C0-AF6E-DB5ED0CCF30FQ35554988-60BC0A5C-BA90-44B9-9898-49276542D16FQ35555306-62AD8252-4DEB-4614-A60E-DAFD24C20D5BQ35555802-02BD13FD-0036-4A3C-860F-4D3A28489615Q35626275-AB9D6144-56AF-4AC1-A0A4-EAB95319D004Q35638233-315B470D-2347-411D-BD5D-F913F5AC826CQ35809286-13C4E4A4-8A65-4AD4-9326-5AE8302C293BQ35931029-11D8D9F6-64B6-4407-84A8-2262B89069DDQ35953484-58703201-883E-4DD2-A7EA-68AE8A52F58FQ36215822-01B55380-7A7C-4522-81C2-05FC97CC64F6Q36903420-25A494C7-D367-4233-9475-CF4D7614F97AQ37205463-A1FE0220-B9D9-40FB-B2D6-78A80DE1D0F8Q37296336-501C7FB2-B883-4E39-805D-12B29C9898A0Q37348534-EBC6422A-E5BA-4B4F-9087-3646B82E0F18Q38664660-4764B658-1436-4731-BE78-90563F6B668CQ40627164-0631F7B1-803E-4708-A356-3FEF2F2AF7FAQ42098153-32251475-CD2D-41D8-9993-478D099D48AAQ42099745-561E2102-63F6-4CD1-BDA3-639A02E93F2CQ42279240-D956C3A1-405D-4FDF-8A44-D718ACAAC4F1Q43049822-EC3F13B2-E4C9-4F72-B6E4-B355555CBDEEQ57821877-43B2651F-E986-45C9-8510-072FEF570E6D
P2860
Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Relative value of erythrocyte ...... ity in ankylosing spondylitis.
@ast
Relative value of erythrocyte ...... ity in ankylosing spondylitis.
@en
type
label
Relative value of erythrocyte ...... ity in ankylosing spondylitis.
@ast
Relative value of erythrocyte ...... ity in ankylosing spondylitis.
@en
prefLabel
Relative value of erythrocyte ...... ity in ankylosing spondylitis.
@ast
Relative value of erythrocyte ...... ity in ankylosing spondylitis.
@en
P2093
P1476
Relative value of erythrocyte ...... ity in ankylosing spondylitis.
@en
P2093
Dougados M
Mielants H
Spoorenberg A
de Klerk E
van der Heijde D
van der Linden S
van der Tempel H
P304
P407
P577
1999-04-01T00:00:00Z